Search research articles
Contact Us
Filters
Showing results (71-80 of 97) with videos related to
Page
of 10
Sort By:
Small (Weinheim an Der Bergstrasse, Germany)
|
September 17, 2013
Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors
Minati Satpathy, Liya Wang, Rafal Zielinski, et al.
Molecular Cancer Therapeutics
|
July 23, 2008
HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair
Thuy T Koll, Steven S Feis, Mollie H Wright, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 15, 2012
PET of HER2-positive pulmonary metastases with 18F-ZHER2:342 affibody in a murine model of breast cancer: comparison with 18F-FDG
Gabriela Kramer-Marek, Marcelino Bernardo, Dale O Kiesewetter, et al.
Journal of Applied Clinical Medical Physics
|
November 21, 2008
Accuracy of 3D volumetric image registration based on CT, MR and PET/CT phantom experiments
Guang Li, Huchen Xie, Holly Ning, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 18, 2020
Current Status of Radiopharmaceutical Therapy
Sara St James, Bryan Bednarz, Stanley Benedict, et al.
JNCI Cancer Spectrum
|
August 5, 2021
Moving Forward in the Next Decade: Radiation Oncology Sciences for Patient-Centered Cancer Care
C Norman Coleman, Jeffrey C Buchsbaum, Pataje G S Prasanna, et al.
Journal of Liposome Research
|
October 22, 2008
HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents
Anu Puri, Gabriela Kramer-Marek, Ryan Campbell-Massa, et al.
Radiation Research
|
August 17, 2022
The State of Preclinical Modeling for Early Phase Cancer Trials Using Molecularly Targeted Agents with Radiation
Julie A Hong, Bhadrasian Vikram, Jeffrey Buchsbaum, et al.
Plos One
|
March 3, 2012
In vivo fluorescence lifetime imaging monitors binding of specific probes to cancer biomarkers
Yasaman Ardeshirpour, Victor Chernomordik, Rafal Zielinski, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 11, 2021
National Cancer Institute support for targeted alpha-emitter therapy
Julie A Hong, Martin Brechbiel, Jeff Buchsbaum, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 97) with videos related to
Sort By:
Page
of 10
Small (Weinheim an Der Bergstrasse, Germany)
|
September 17, 2013
Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors
Minati Satpathy, Liya Wang, Rafal Zielinski, et al.
Molecular Cancer Therapeutics
|
July 23, 2008
HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair
Thuy T Koll, Steven S Feis, Mollie H Wright, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 15, 2012
PET of HER2-positive pulmonary metastases with 18F-ZHER2:342 affibody in a murine model of breast cancer: comparison with 18F-FDG
Gabriela Kramer-Marek, Marcelino Bernardo, Dale O Kiesewetter, et al.
Journal of Applied Clinical Medical Physics
|
November 21, 2008
Accuracy of 3D volumetric image registration based on CT, MR and PET/CT phantom experiments
Guang Li, Huchen Xie, Holly Ning, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 18, 2020
Current Status of Radiopharmaceutical Therapy
Sara St James, Bryan Bednarz, Stanley Benedict, et al.
JNCI Cancer Spectrum
|
August 5, 2021
Moving Forward in the Next Decade: Radiation Oncology Sciences for Patient-Centered Cancer Care
C Norman Coleman, Jeffrey C Buchsbaum, Pataje G S Prasanna, et al.
Journal of Liposome Research
|
October 22, 2008
HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents
Anu Puri, Gabriela Kramer-Marek, Ryan Campbell-Massa, et al.
Radiation Research
|
August 17, 2022
The State of Preclinical Modeling for Early Phase Cancer Trials Using Molecularly Targeted Agents with Radiation
Julie A Hong, Bhadrasian Vikram, Jeffrey Buchsbaum, et al.
Plos One
|
March 3, 2012
In vivo fluorescence lifetime imaging monitors binding of specific probes to cancer biomarkers
Yasaman Ardeshirpour, Victor Chernomordik, Rafal Zielinski, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 11, 2021
National Cancer Institute support for targeted alpha-emitter therapy
Julie A Hong, Martin Brechbiel, Jeff Buchsbaum, et al.
Page
of 10